Alvotech (ALVO) Reports Prelim Q2 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Deutsche Bank Reiterates Hold Rating on Alvotech SA (ALVO), 'we continue to monitor ongoing Simlandi RX trends in the US'
July 2, 2024 1:02 PM EDTDeutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating and $14.00 price target on Alvotech SA (NASDAQ: ALVO).
The analyst comments "ALVO yesterday reported a Q2 sales beat of c41%/c31% for DB/cons, respectively. Top-line performance was primarily driven by achievement of clinical... More
